Vita 34 AG / Key word(s): Preliminary Results 04.03.2014 11:01 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Vita 34 AG announces preliminary, unaudited results for the fiscal year 2013 Leipzig, 4 March 2014 - Vita 34 AG (WKN A0BL84), the largest private stem cell bank in the German-speaking countries, announces preliminary, unaudited results according to the International Reporting Standards (IFRS) for the fiscal year 2013. For the fiscal year 2013 Vita 34 AG expects to generate revenue on about the same level of the previous year with 13.6 million Euro (2012: 13.6 million Euro) and earnings before interest, taxes, depreciation and amortization (EBITDA) of approximately 2.7 million Euro (2012: 0.4 million Euro) and thus exceeds the estimation published on 24 October 2013. 04.03.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Vita 34 AG Deutscher Platz 5a 04103 Leipzig Germany Phone: +49(0341)48792-40 Fax: +49(0341)48792-39 E-mail: [email protected] Internet: www.vita34.de ISIN: DE000A0BL849 WKN: A0BL84 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------